Oriental Aromatics Ltd. · NSE:OAL
Oriental Aromatics — Q4 FY20 Earnings Presentation
22 slides from Oriental Aromatics's earnings presentation, Jul 1, 2020
Slide 1: Regulation 30 disclosure cover letter to stock exchanges
Ref: OAL/BSE/NSE/15/2020-21 1st July, 2020 To To The Manager The Manager Department of Corporate Services, Listing Department, BSE Limited, National Stock Exchange of India Limited Phiroz Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai- 400 001 Bandra (East), Mumbai - 400
Slide 2: Earnings Presentation Q4-FY20 / FY20
EARNINGS PRESENTATION | Q4-FY20 / FY20
Slide 3: Executive Summary
Executive Summary Overview • Oriental Aromatics Ltd. is one of the largest Indian manufacturers of a variety of Aroma Chemicals, Camphor, Fragrances and Flavours. • The company is one of the privileged few integrated manufacturers of fragrances and flavours as well as aroma chemicals globally. • The
Slide 4: Company Overview
3 Company Overview
Slide 5: Company Overview
Company Overview • The Fragrance and Flavours business of Oriental Aromatics was founded by Mr. Keshavlal Bodani in Fragrances 1955 and has been nurtured and handed down to three generations of the Bodani’s. • In August 2008, Oriental Aromatics’ promoters acquired a controlling stake of 57.66% in th
Slide 6: Value Chain
Value Chain Sources of Raw Raw Materials Products/Blends Applications Materials Aroma Ingredients Incense Sticks Speciality Aroma Chemicals Pine Oil Air Fresheners Terpene based aroma chemicals Pine Tree Others Cosmetics Synthetic Camphor Alpha Pinene Pooja Fragrance and Flavour Products Petroleum B
Slide 7: Q4-FY20 Financial Overview
6 Q4-FY20 Financial Overview
Slide 8: Q4-FY20 / FY20 Financial Highlights
Q4-FY20 / FY20 Financial Highlights Q4-FY20 Consolidated Performance: • Revenue from Operations: INR 1,697 Mn • EBITDA : INR 356 Mn • EBITDA Margins: 20.98% • Net Profit: INR 239 Mn • PAT Margins: 14.08% • Basic/Diluted EPS: INR 7.09 per share FY20 Consolidated Performance: • Revenue from Operations
Slide 9: Q4-FY20 / FY20 Operational Highlights
Q4-FY20 / FY20 Operational Highlights • The company witnessed better demand for specialty aroma chemicals, which resulted in higher volume of production and value of sales as compared to the previous financial year. • Despite reduction in the Raw material prices the company was able to hold on to th
Slide 10: Q4-FY20 Standalone Income Statement (IND-AS)
Q4-FY20 Standalone Income Statement (IND-AS) Particulars (INR Mn) Q4-FY20 Q4-FY19 Y-O-Y Q3-FY20 Q-O-Q Revenue from Operations 1,697 2,010 (15.6)% 1,754 (3.2)% Total Expenses 1,336 1,696 (21.2)% 1,474 (9.4)% EBITDA 361 314 15.0% 280 28.9% EBITDA Margin (%) 21.27% 15.62% 565 Bps 15.96% 531 Bps Other I
Slide 11: FY20 Standalone Income Statement (IND-AS)
FY20 Standalone Income Statement (IND-AS) Particulars (INR Mn) FY20 FY19 Y-O-Y Revenue from Operations 7,594 7,526 0.9% Total Expenses 6,319 6,372 (0.8)% EBITDA 1,275 1,154 10.5% EBITDA Margin (%) 16.79% 15.33% 146 Bps Other Income 70 13 NA Depreciation 190 177 7.3% Finance Cost 120 130 (7.7)% Excep
Slide 12: Q4-FY20 Consolidated Income Statement (IND-AS)
Q4-FY20 Consolidated Income Statement (IND-AS) Particulars (INR Mn) Q4-FY20 Q3-FY20 Q-O-Q Revenue from Operations 1,697 1,754 (3.2)% Total Expenses 1,341 1,471 (8.8)% EBITDA 356 283 25.8% EBITDA Margin (%) 20.98% 16.13% 485 Bps Other Income 39 12 NA Depreciation 51 47 8.5% Finance Cost 36 17 NA PBT
Slide 13: FY20 Consolidated Income Statement (IND-AS)
FY20 Consolidated Income Statement (IND-AS) Particulars (INR Mn) FY20 FY19 Y-O-Y Revenue from Operations 7,599 7,547 0.7% Total Expenses 6,335 6,397 (1.0)% EBITDA 1,264 1,150 9.9% EBITDA Margin (%) 16.63% 15.24% 139 Bps Other Income 74 13 NA Depreciation 190 178 6.7% Finance Cost 119 130 (8.5)% Exce
Slide 14: Historical Financial Overview
13 Historical Financial Overview
Slide 15: Historical Standalone Income Statement (IND-AS)
Historical Standalone Income Statement (IND-AS) Income Statement (Mn) FY18 FY19 FY20 Total Operational Income 5,057 7,526 7,594 Total Expenses 4,398 6,375 6,319 EBITDA 659 1,151 1,275 EBITDA Margin (%) 13.03% 15.29% 16.79% Depreciation 148 177 70 Interest 69 127 190 Other Income 41 13 120 Exceptiona
Slide 16: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet Liabilities (INR Mn) FY19 FY20 Assets (INR Mn) FY19 FY20 Shareholders Fund Assets Share Capital 168 168 Non-Current Assets Other Equity 3,752 4,470 Property, Plant and Equipment 1,941 1,814 Intangible Asset 58 24 Non-Current Liabilities Capital WIP 8 17 Financial
Slide 17: Historical Consolidated Income Statement (IND-AS)
Historical Consolidated Income Statement (IND-AS) Income Statement (Mn) FY18 FY19 FY20 Total Operational Income 5,060 7,547 7,599 Total Expenses 4,413 6,400 6,335 EBITDA 647 1,147 1,264 EBITDA Margin (%) 12.79% 15.20% 16.63% Depreciation 148 178 190 Interest 73 127 119 Exceptional Item - (23) - Othe
Slide 18: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet Liabilities (INR Mn) FY19 FY20 Assets (INR Mn) FY19 FY20 Shareholders Fund Assets Share Capital 168 168 Non-Current Assets Other Equity 3,751 4,473 Property, Plant and Equipment 1,941 1,815 Goodwill 450 450 Capital WIP 8 18 Financial Liabilities Intangible Asset
Slide 19: Financial Performance (Consolidated)
Financial Performance (Consolidated) Revenue from Operations (INR Mn) EBITDA (INR Mn) EBITDA MARGIN (%) PAT (INR Mn) PAT MARGIN (%) 16.63% 11.34% 15.20% 18.00% 16.00% 7,599 7,547 12.41% 12.79% 1,264 14.00% 862 7.57% 1,147 12.00% 6.10% 10.00% 4.94% 5,060 4,577 571 8.00% 647 6.00% 568 4.00% 279 250 2.
Slide 20: Capital Market Information
Capital Market Information 20% 10% 0% -10% -20% -30% -40% -50% Apr-19 May-19 Jun-19 Jul-19 Aug-19 Sep-19 Oct-19 Nov-19 Dec-19 Jan-20 Feb-20 Mar-20 OAL Sensex Price Data (31st March, 2020) INR Shareholding Pattern as on 31st March, 2020 Face Value 5.0 CMP 134.1 52 Week H/L (INR) 243.00/117.05 Public
Slide 21: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Oriental Aromatics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any s
Slide 22: Ohiental homaties Lid
Ohiental homaties Lid